These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 10053167

  • 1. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Drahushuk AT, McGarrigle BP, Slezak BP, Stegeman JJ, Olson JR.
    Toxicol Appl Pharmacol; 1999 Mar 01; 155(2):127-38. PubMed ID: 10053167
    [Abstract] [Full Text] [Related]

  • 2. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
    Drahushuk AT, McGarrigle BP, Tai HL, Kitareewan S, Goldstein JA, Olson JR.
    Toxicol Appl Pharmacol; 1996 Oct 01; 140(2):393-403. PubMed ID: 8887457
    [Abstract] [Full Text] [Related]

  • 3. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ, Akubue PI, Luebke RW, Birnbaum LS.
    Toxicol Appl Pharmacol; 1995 Feb 01; 130(2):197-208. PubMed ID: 7871533
    [Abstract] [Full Text] [Related]

  • 4. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
    Andersen ME, Birnbaum LS, Barton HA, Eklund CR.
    Toxicol Appl Pharmacol; 1997 May 01; 144(1):145-55. PubMed ID: 9169078
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW, Sutter TR.
    Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):279-86. PubMed ID: 9931287
    [Abstract] [Full Text] [Related]

  • 6. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM, Goldstein JA, Portier CJ, McCoy Z, Clark GC, Lucier GW.
    Cancer Res; 1992 Jun 15; 52(12):3436-42. PubMed ID: 1596902
    [Abstract] [Full Text] [Related]

  • 7. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA, McGarrigle BP, Sutter TR, Olson JR.
    Toxicol In Vitro; 2006 Jun 15; 20(4):426-38. PubMed ID: 16198082
    [Abstract] [Full Text] [Related]

  • 8. 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes.
    Xu L, Li AP, Kaminski DL, Ruh MF.
    Chem Biol Interact; 2000 Feb 01; 124(3):173-89. PubMed ID: 10728777
    [Abstract] [Full Text] [Related]

  • 9. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ, Beebe LE, Menache M, Birnbaum LS.
    J Toxicol Environ Health; 1996 Mar 01; 47(4):379-94. PubMed ID: 8600290
    [Abstract] [Full Text] [Related]

  • 10. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
    Santostefano MJ, Ross DG, Savas U, Jefcoate CR, Birnbaum LS.
    Biochem Biophys Res Commun; 1997 Apr 07; 233(1):20-4. PubMed ID: 9144388
    [Abstract] [Full Text] [Related]

  • 11. Cytochrome P450 1A1 induction in rat lymphoid tissues following in vivo and in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin requires protein kinase C.
    Stephen FD, Drahushuk AT, Olson JR.
    Toxicology; 1997 Dec 19; 124(1):39-51. PubMed ID: 9392454
    [Abstract] [Full Text] [Related]

  • 12. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Nov 19; (531):1-218. PubMed ID: 17342196
    [Abstract] [Full Text] [Related]

  • 13. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells.
    Stegeman JJ, Hahn ME, Weisbrod R, Woodin BR, Joy JS, Najibi S, Cohen RA.
    Mol Pharmacol; 1995 Feb 19; 47(2):296-306. PubMed ID: 7870038
    [Abstract] [Full Text] [Related]

  • 14. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
    Santostefano MJ, Wang X, Richardson VM, Ross DG, DeVito MJ, Birnbaum LS.
    Toxicol Appl Pharmacol; 1998 Aug 19; 151(2):294-310. PubMed ID: 9707506
    [Abstract] [Full Text] [Related]

  • 15. Effect of the histone deacetylase inhibitor trichostatin A on the responsiveness of rat hepatocytes to dioxin.
    Xu L, Ruh TS, Ruh MF.
    Biochem Pharmacol; 1997 Apr 04; 53(7):951-7. PubMed ID: 9174108
    [Abstract] [Full Text] [Related]

  • 16. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls.
    DeVito MJ, Ménache MG, Diliberto JJ, Ross DG, Birnbaum LS.
    Toxicol Appl Pharmacol; 2000 Sep 15; 167(3):157-72. PubMed ID: 10986007
    [Abstract] [Full Text] [Related]

  • 17. Bifunctional modulating effects of an indigo dimer (bisindigotin) to CYP1A1 induction in H4IIE cells.
    Lai KP, Mak NK, Wei X, Wong RN, Wong MH, Wong CK.
    Toxicology; 2006 Sep 21; 226(2-3):188-96. PubMed ID: 16901605
    [Abstract] [Full Text] [Related]

  • 18. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
    Vogel C, Donat S, Döhr O, Kremer J, Esser C, Roller M, Abel J.
    Arch Toxicol; 1997 Sep 21; 71(6):372-82. PubMed ID: 9195019
    [Abstract] [Full Text] [Related]

  • 19. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Sep 21; (526):1-180. PubMed ID: 17342195
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
    Moore M, Narasimhan TR, Steinberg MA, Wang X, Safe S.
    Arch Biochem Biophys; 1993 Sep 21; 305(2):483-8. PubMed ID: 8396892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.